Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Find out what to include in a balanced crypto investment. Create a diversified portfolio that aligns with your investment goals.
23,214 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
A pivotal moment in AI memory stocks could propel a leading name higher after Micron's earnings. This article breaks ...
Markets surge after a peace deal championed by former President Trump propels a broad risk-on rally, even as analysts...
A potential Dow reshuffle could end Nike's long run in the index and swap it for a consumer-facing giant. This articl...
A high-profile insider sale can spark questions about a company’s future. This article breaks down the HeartFlow CEO'...
A tech-focused investor known for hunting winners, billionaire Philippe Laffont just rotated from a high-profile AI p...
Leveraged ETFs promise amplified moves, but they can amplify losses just as quickly. This guide breaks down why lever...
VCR is down about 9% year-to-date, but nearly 40% of its holdings sit in Amazon and Tesla, reshaping the fund’s risk ...
Market pullbacks can feel daunting, but they’re prime opportunities for long-term gains. This guide reveals how to id...
Investors nudged Intel higher after AI infrastructure news signaled stronger demand for its CPU and accelerator lineu...
In mid-June, hawkish central bank signals set the tone for global markets. The FTSE 100 faltered while the Nikkei 225...
Pfizer signals it can bankroll ambitious deals with a robust balance sheet. This article weighs what a 'very big' bal...